DMTK's logo.
Ticker Symbol: DMTK

DermTech Inc

$23.59 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001651944

Company Profile

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform dermatology with its non-invasive skin genomics platform, to democratize access to high quality dermatology care, and to improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments.

Sector: Health Care and Social Assistance
Industry: Diagnostic Imaging Centers
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
Website: dermtech.com
CEO: N/A
Tags:
  • Finance
  • Financial Conglomerates
  • Health Technology
  • Medical Specialties

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $1.40
Change: -$0.07 ( -4.76%)
Days Range: $1.39 - $1.48
Beta: 1.56
52wk. High: $6.44
52wk. Low: $1.14
Ytd. Change -21.71%
50 Day Moving Average: $1.63
200 Day Moving Average: $2.60
Shares Outstanding: 33700000

Valuation

Market Cap: 4.7B
PE Ratio: -
EPS (TTM): -3.9

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A